Correlation Between Onconova Therapeutics and Acasti Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Onconova Therapeutics and Acasti Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onconova Therapeutics and Acasti Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Onconova Therapeutics and Acasti Pharma, you can compare the effects of market volatilities on Onconova Therapeutics and Acasti Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onconova Therapeutics with a short position of Acasti Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onconova Therapeutics and Acasti Pharma.

Diversification Opportunities for Onconova Therapeutics and Acasti Pharma

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Onconova and Acasti is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Onconova Therapeutics and Acasti Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acasti Pharma and Onconova Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onconova Therapeutics are associated (or correlated) with Acasti Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acasti Pharma has no effect on the direction of Onconova Therapeutics i.e., Onconova Therapeutics and Acasti Pharma go up and down completely randomly.

Pair Corralation between Onconova Therapeutics and Acasti Pharma

If you would invest  256.00  in Acasti Pharma on September 3, 2024 and sell it today you would earn a total of  81.00  from holding Acasti Pharma or generate 31.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy2.5%
ValuesDaily Returns

Onconova Therapeutics  vs.  Acasti Pharma

 Performance 
       Timeline  
Onconova Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Onconova Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Onconova Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Acasti Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Acasti Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively weak basic indicators, Acasti Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Onconova Therapeutics and Acasti Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Onconova Therapeutics and Acasti Pharma

The main advantage of trading using opposite Onconova Therapeutics and Acasti Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onconova Therapeutics position performs unexpectedly, Acasti Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will offset losses from the drop in Acasti Pharma's long position.
The idea behind Onconova Therapeutics and Acasti Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins